CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

STUDIES

Studies

“We support pharmaceutical companies to effectively meet the growing real-world data requirements with observational studies for better outcomes or greater value”

Our ethos is to encourage original scientific thought and innovation so that projects benefit from the best design and execution.

1

PRIMARY/ FIELD STUDIES

We work seamlessly with our partners to ensure that the specific requirements of real-world evidence are met in the most cost-effective way.

2

SECONDARY DATABASE STUDIES

We understand that matching research objectives with the capabilities of local data sources is an essential step in undertaking valid and credible research.

3

HYBRID STUDIES

We combine elements of different study designs and data sources to maximise balance of validity, reliability, efficiency, costs and practicality and build a bespoke approach tailored to study objectives.

PRIMARY/FIELD STUDIES

OXON offers single and multi-country studies (Cohort, Case Control, Cross-Sectional and Surveys) using retrospective, prospective and cross-sectional data collection methodologies for safety, Market Access/HEOR and Drug Development.

DATABASE STUDIES

OXON provides clients with single and multi-country database studies (Cohort, Case Control, Cross-Sectional) using secondary data sources to satisfy client’s requirements for safety, Market Access/HEOR and Drug Development.

HYBRID STUDIES

OXON supports sponsors to fill evidence gaps and generate RWE through the most valid, reliable, efficient, cost-effective, and practical hybrid approaches. Our ability to combine data collection with secondary data allows an accurate approach to study objectives.

Study designs

OXON provides a unique blend of observational science and operational excellence to our clients as fellow scientists

At OXON we advise clients frankly on the advantages and disadvantages of their study options while  our experts help determine the right type of study according to the time, cost, and regulatory implications. 

""

PATIENT REGISTRIES

Patient registries provide a real-world view of clinical practice, patient outcomes, safety, comparative and cost-effectiveness, and serve to evidence development and decision-making purposes.

""

PRAGMATIC TRIALS

OXON offers sponsors its expertise and experience in pragmatic trials using data collection and secondary data sources with pharmacological, diagnostic, device, educational and behavioural interventions to help bridge the gap between trials and real-world evidence for Safety and Market Access/HEOR.

""

SYSTEMATIC REVIEWS
& META-ANALYSIS

We use systematic methods to collect secondary data to appraise and synthesise the best available evidence on a defined question and offer statistical approaches to combining the data derived from any systematic review.

""

PASS & PAES STUDIES

We assist our clients in designing and conducting post-authorisation safety/efficacy studies, always under the ENCePP guide on methodological standards in pharmacoepidemiology and Code of Conduct.

""

RISK MINIMISATION STUDIES

OXON delivers studies measuring the effectiveness of routine and additional risk minimization measures (RMMs) for products in most therapy areas and global risk minimisation approaches.

""

MARKET ACCESS/HEOR

We specialise in the use of health economics and patient-reported outcomes within observational studies to help collect the evidence needed to prove the cost-effectiveness of drugs, diagnostics, devices, educational and behavioural interventions and address the evidence needed for stakeholders.

Contact us! It will only take a minute

CONTACT US